Hannah Bolt, PhD, MBAHead of Peptide Discovery at AstraZenecaSpeaker
Profile
Dr Hannah Bolt, MBA is Head of Peptide Discovery at AstraZeneca. Hannah is an emerging leader in the peptide pharmaceutical field, with >10 years’ experience in peptide drug discovery and has delivered several peptide candidates that are now moving through clinical phases of development. Hannah champions scientific excellence as a sponsor for the adoption of disruptive and emerging technologies, is an active member of the external chemistry community and a passionate STEM ambassador, mentoring the next generation of scientists.
Agenda Sessions
Peptide-Targeted Delivery of Oligonucleotide Therapeutics
, 09:05View Session
